Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
- 10 April 1997
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 71 (2) , 142-147
- https://doi.org/10.1002/(sici)1097-0215(19970410)71:2<142::aid-ijc3>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.The Journal of Experimental Medicine, 1995
- Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selectionEuropean Journal of Immunology, 1995
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Lymphokine Production by Human T Cells in Disease StatesAnnual Review of Immunology, 1994
- Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.The Journal of Experimental Medicine, 1993
- Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.Journal of Clinical Investigation, 1993
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanomaPathology, 1987
- A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17Human Immunology, 1980